Retrograde Technique: High Success Rate in CTO

Original Title: Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry.

Reference: Dimitri Karmpaliotis et al. Circ Cardiovasc Interv. 2016 Jun;9(6).

 

Retrograde Technique CTOThis study evaluated the safety and efficacy of the retrograde technique for chronic total occlusions. Researchers compared retrograde vs. anterograde technique outcomes in 1,301 procedures from 11 experienced centers across the US between the years 2012 and 2015.

Population mean age was 65.5±10 years with high diabetes prevalence (45%) and prior MI revascularization surgery (34%).

Globally, technical success was 90%, which reflects the experience of these centers, and major cardiovascular adverse events rate was 2.4%.

The retrograde technique was used in 539 cases (41%), both as initial strategy (46%) and after a failed anterograde attempt (54%).

Comparing both techniques, the retrograde technique was used in more complex cases, both from the clinical (prior surgery 48% vs. 24%; p<0.001) and angiographic point of views (mean Japan CTO score 3.1±1.0 vs 2.1±1.2; p<0.001) and resulted in lower technical success (85% vs. 94%; p<0.001) and higher complications rate (4.3% vs 1.1%; p<0.001).

Multivariable analyzis showed that the presence of suitable collaterals, no prior CABG and the left anterior descending artery as target vessel were success predictors for the retrograde technique.

Conclusion

The retrograde approach is commonly used in the daily contemporary practice especially on most challenging lesions and patients. Despite lower success and higher complications rates compared to the anterograde technique, it is an essential tool to maintain high success rates in chronic total occlusions.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...